Medindia
Medindia LOGIN REGISTER
Advertisement

Transdermal Drug Patches to 2024

Wednesday, December 6, 2017 Drug News
Advertisement
NEW YORK, Dec. 5, 2017 /PRNewswire/ -- Transdermal drug patches to 2024 analyzes products, markets and commercialization factors for drug patches. The report examines the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver.
Advertisement

Read the full report: https://www.reportlinker.com/p01941669

Advances in synthetic materials and patch design have led to patches that are more aesthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2024.
Advertisement

What You Will Learn• What are the current transdermal drug patch markets and products, and what is the market potential for existing and probable future products?• What is the impact of patch designs, technologies and patch development issues on commercialization?• Who are the leading patch manufacturers and third-party transdermal supply chain companies?• What is the current product and competitive landscape, and what are the details of the numerous products across the various patch product categories and markets?• What is the size of the market now, and how will it change in the next seven years to 2024?• Who are the transdermal drug patch product providers, and what are their product development activity, and strategies?• What is the market impact of economic, technology, and regulatory factors?

Read the full report: https://www.reportlinker.com/p01941669

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

 

View original content:http://www.prnewswire.com/news-releases/transdermal-drug-patches-to-2024-300567462.html

SOURCE Reportlinker

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close